John C. Raney

Counsel

Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.

pdf

John Raney maintains a broad mergers and acquisition practice, encompassing public and private acquisitions, dispositions, tender offers, co-investments, joint ventures, and venture financing. John represents public and private companies, and private equity firms, in transactions involving US and non-US companies across a wide range of industries, from health care to retail, manufacturing, real estate, and beyond. He also counsels clients in general corporate matters and has represented issuers and underwriters in numerous debt and equity securities offerings.

Approaching matters with a broad vision of the issues that confront businesses, John crafts creative and constructive solutions to help his clients advance their interests. He is a member of the Mergers & Acquisitions Practice.

Admissions

Bar Admissions

  • California

Education

  • University of California at Los Angeles, J.D.
  • Boston College, B.A.: Philosophy (2002)
  • Represented a medical diagnostic company in its US$600 sale to an international health care company.
  • Represented middle-market private equity firms in numerous acquisitions, divestitures and investments.
  • Represented a public pharmaceutical company in its US$5.6 billion sale to an international pharmaceutical company.
  • Represented a real estate investment trust in its US$7.4 billion merger with another real estate investment trust.